NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
251 Kalmar |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 69 | 0.5% | 9 | 0.1% | . | . | 2 | 0.0% | . | . | . | . | 4 | 0.0% | 13882 | 99.4% | 13966 | 100.0% |
ASCUS | 19 | 4.0% | 33 | 6.9% | . | . | 35 | 7.3% | 1 | 0.2% | . | . | 6 | 1.3% | 385 | 80.4% | 479 | 100.0% |
CIN1 | 27 | 8.8% | 65 | 21.2% | . | . | 52 | 17.0% | . | . | 1 | 0.3% | 5 | 1.6% | 156 | 51.0% | 306 | 100.0% |
Atypical glandular cells/AGC | 3 | 27.3% | 3 | 27.3% | . | . | . | . | 2 | 18.2% | 1 | 9.1% | 1 | 9.1% | 1 | 9.1% | 11 | 100.0% |
Unclear atypia | 7 | 26.9% | 4 | 15.4% | . | . | 8 | 30.8% | . | . | . | . | 2 | 7.7% | 5 | 19.2% | 26 | 100.0% |
ASC-H | 3 | 3.5% | 12 | 14.1% | . | . | 63 | 74.1% | 1 | 1.2% | 1 | 1.2% | 1 | 1.2% | 4 | 4.7% | 85 | 100.0% |
CIN3 | . | . | 4 | 3.8% | . | . | 93 | 89.4% | 2 | 1.9% | 2 | 1.9% | . | . | 3 | 2.9% | 104 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | 2 | 40.0% | 3 | 60.0% | . | . | . | . | . | . | 5 | 100.0% |
Squamous cell cancer | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | 1 | 100.0% |
Total | 128 | 0.9% | 130 | 0.9% | . | . | 255 | 1.7% | 9 | 0.1% | 6 | 0.0% | 19 | 0.1% | 14436 | 96.3% | 14983 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81409 |